Skip to main content

ERRATUM article

Front. Immunol., 07 October 2021
Sec. Cancer Immunity and Immunotherapy
Volume 12 - 2021 | https://doi.org/10.3389/fimmu.2021.782687

Erratum: Immunotherapy for Glioblastoma: Current Progress and Challenges

This article is an erratum on:

  1. Immunotherapy for Glioblastoma: Current Progress and Challenges

    1. Read original article
Frontiers Production Office* Frontiers Production Office*
  • Frontiers Media SA, Lausanne, Switzerland

An erratum on
Immunotherapy for Glioblastoma: Current Progress and Challenges

by Yu MW and Quail DF (2021). Front. Immunol. 12:676301. doi: 10.3389/fimmu.2021.676301

Due to a production error, there was an error in the Article Title. The final “s” of “Challenges” was missed from the end of the title.

The publisher apologizes for this mistake. The original version of this article has been updated.

Keywords: glioblastoma, brain cancer, immunotherapy, tumor microenvironment, resistance to therapy

Citation: Frontiers Production Office (2021) Erratum: Immunotherapy for Glioblastoma: Current Progress and Challenges. Front. Immunol. 12:782687. doi: 10.3389/fimmu.2021.782687

Received: 24 September 2021; Accepted: 24 September 2021;
Published: 07 October 2021.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2021 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Production Office, cHJvZHVjdGlvbi5vZmZpY2VAZnJvbnRpZXJzaW4ub3Jn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.